Market Midday: Stocks Mixed, Winning 6 Months for Investors, FDA Approves New Amgen Cancer Drug 5/17/24

From Wall Street to Main Street, the latest on the markets and what it means for your money. Updated regularly on weekdays, featuring CNBC expert analysis and sound from top business newsmakers. Anchored and reported by CNBC's Jessica Ettinger.